Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-2021 | 07-2021 | 04-2021 | 01-2021 | 10-2020 | |
| Operating Expenses | 1,005 | 1,023 | 1,035 | 757 | 950 |
| Operating Income | -1,005 | -1,023 | -1,035 | -757 | -950 |
| Interest Expense | 0 | 1 | 2 | 0 | 1 |
| Other Income | 25 | -2 | 77 | 0 | 0 |
| Pre-tax Income | -980 | -1,025 | -960 | -757 | -950 |
| Net Income Continuous | -980 | -1,025 | -960 | -757 | -950 |
| Net Income | $-980 | $-1,025 | $-960 | $-757 | $-950 |
| EPS Basic Total Ops | -0.06 | -0.64 | -0.55 | -0.49 | -0.62 |
| EPS Basic Continuous Ops | -0.06 | -0.64 | -0.56 | -0.49 | -0.62 |
| EPS Diluted Total Ops | -0.06 | -0.64 | -0.55 | -0.49 | -0.62 |
| EPS Diluted Continuous Ops | -0.06 | -0.64 | -0.56 | -0.49 | -0.62 |
| EBITDA(a) | $-1,005 | $-1,023 | $-1,035 | $-757 | $-950 |